Cutting Edge: In Vitro-Generated Tolerogenic APC Induce CD8+ T Regulatory Cells That Can Suppress Ongoing Experimental Autoimmune Encephalomyelitis

Journal of Immunology

Volumn 172, Issue 4, 2004, Pages 1991-1995

  Faunce, Douglas E ^a,c   Terajewicz, Ania ^a   Stein Streilein, Joan ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MYELIN BASIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA2;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 0842321793     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.4.1991     Document Type: Article

References (36)

1. Wilbanks, G. A., M. Mammolenti, and J. W. Streilein. 1992. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β. Eur. J. Immunol. 22:165.
2. Wilbanks, G. A., and J. W. Streilein. 1991. Studies on the induction of anterior chamber-associated immune deviation (ACAID). I. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J. Immunol. 146:2610.
3. D'Orazio, T. J., and J. Y. Niederkorn. 1998. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 95:47.
4. Sonoda, K. H., and J. Stein-Streilein. 2002. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32:848.
5. Sonoda, K. H., M. A. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein. 1999. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190:1215.
6. Xu, Y., and J. A. Kapp. 2001. γδ T cells are critical for the induction of anterior chamber-associated immune deviation. Immunology 104:142.
7. + CTL responses. Invest. Ophthalmol. Visual Sci. 43:3473.
8. Faunce, D. E., K. H. Sonoda, and J. Stein-Streilein. 2001. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166:313.
9. Sonoda, K. H., D. E. Faunce, M. Taniguchi, M. A. Exley, S. Balk, and J. Stein-Streilein. 2001. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166:42.
10. Streilein, J. W., and J. Y. Niederkorn. 1985. Characterization of the suppressor cell(s) responsible for anterior chambet-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. J. Immunol. 134:1381.
11. Wilbanks, G. A., and J. W. Streilein. 1990. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen: evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 71:383.
12. Takeuchi, M., P. Alard, and J. W. Streilein. 1998. TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 160:1589.
13. Takeuchi, M., M. M. Kosiewicz, P. Alard, and J. W. Streilein. 1997. On the mechanisms by which transforming growth factor-β2 alters antigen-presenting abilities of macrophages on T cell activation. Eur. J. Immunol. 27:1648.
14. Streilein, J. W. 1997. Molecular basis of ACAID. Ocul. Immunol. Inflamm. 5:217.
15. Kosiewicz, M. M., S. Okamoto, S. Miki, B. R. Ksander, T. Shimizu, and J. W. Streilein. 1994. Imposing deviant immunity on the presensitized state. J. Immunol. 153:2962.
16. Okamoto, S., M. M. Kosiewicz, R. R. Caspi, and J. W. Streilein. 1994. ACAID as a potential therapy for establishmental autoimmune uveitis. In Advances in Ocular Immunology. R. B. Nussenblatt, S. M. Whitcup, R. R. Caspi, and I. Gery, eds. Elsevier Science, Amsterdam, p. 195.
17. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J. Immunol. 159:2240.
18. Sakaguchi, S. 2001. Animal models of autoimmunity and their relevance to human diseases. Curr. Opin. Immunol. 12:684.
19. + T cells appearing in the subarachnoid space of rats with autoimmune encephalomyelitis. Eur. J. Immunol. 26:1328.
20. Exley, M. A., Q. He, O. Cheng, R. J. Wang, C. P. Cheney, S. P. Balk, and M. J. Koziel. 2002. Cutting edge: compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. J. Immunol. 168:1519.
21. Exley, M. A., S. M. Tahir, O. Cheng, A. Shaulov, R. Joyce, D. Avigan, R. Sackstein, and S. P. Balk. 2001. A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J. Immunol. 167:5531.
22. Pal, E., T. Tabira, T. Kawano, M. Taniguchi, S. Miyake, and T. Yamamura. 2001. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells. J. Immunol. 166:662.
23. Exley, M. A., N. J. Bigley, O. Cheng, S. M. Tahir, S. T. Smiley, Q. L. Carter, H. F. Stills, M. J. Grusby, Y. Koezuka, M. Taniguchi, and S. P. Balk. 2001. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukocyte Biol. 69:713.
24. Cui, J., N. Watanabe, T. Kawano, M. Yamashita, T. Kamara, C. Shimizu, M. Kimuta, E. Shimizu, J. Koike, H. Koseki, et al. 1999. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J. Exp. Med. 190:783.
25. Tahir, S. M., O. Cheng, A. Shaulov, Y. Koezuka, G. J. Bubley, S. B. Wilson, S. P. Balk, and M. A. Exley. 2001. Loss of IFN-γ production by invariant NK T cells in advanced cancer. J. Immunol. 167:4046.
26. Karagiri, K., J. Zhang-Hoover, J. S. Mo, J. Stein-Streilein, and J. W. Streilein. 2002. Using tolerance induced via the anterior chamber of the eye to inhibit Th2-dependent pulmonary pathology. J. Immunol. 169:84.
27. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchtoo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161:3299.
28. Wilbanks, G. A., and J. W. Streilein. 1992. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg. Immunol. 4:130.
29. Wang, Y., I. Goldschneider, J. O'Rourke, and R. E. Cone. 2001. Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation. J. Leukocyte Biol. 69:741.
30. Stein-Streilein, J., K. H. Sonoda, D. Faunce, and J. Zhang-Hoover. 2000. Regulation of adaptive immune responses by innate cells expressing NK markets and antigen-transporting macrophages. J. Leukocyte Biol. 67:488.
31. Menges, M., S. Rossner, C. Voigtlander, H. Schindler, N. A. Kukutsch, C. Bogdan, K. Erb, G. Schuler, and M. B. Lutz. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195:15.
32. + T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J. Exp. Med. 188:1875.
33. + T cells in EAE mice. Proc. Natl. Acad. Sci. USA 98:6301.
34. + T cells fine-tune the myelin basic protein-reactive T cell receptor Vβ repertoire during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 100:8378.
35. Streilein, J. W. 1999. Immunoregulatory mechanisms of the eye. Prog. Retin. Eye Res. 18:357.
36. D'Orazio, T. J., E. Mayhew, and J. Y. Niederkorn. 2001. Ocular immune privilege promoted by the presentation of peptide on rolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J. Immunol. 166:26.